168 results on '"Mizutani, Hideaki"'
Search Results
2. Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial
3. First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1
4. Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
5. Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1
6. Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)
7. First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
8. Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations
9. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
10. First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
11. Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer
12. Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101)
13. MO1-1 LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab + ipilimumab +/- chemotherapy for NSCLC in Japan
14. Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
15. Data from MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
16. Supplementary Figure 2 from MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
17. Supplementary Figure 1 from MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
18. Euler–Lagrange model for local scour and grain size variation around a spur dyke
19. P29-1 LIGHT-NING: An observational study of nivolumab plus ipilimumab with or without chemotherapy for 1st line NSCLC in Japan
20. Bed morphology and grain size characteristics around a spur dyke
21. First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients (pts) with metastatic non–small cell lung cancer (NSCLC): 3-year update from CheckMate 9LA.
22. Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
23. Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
24. 全球波浪予報値とニューラルネットワークを用いた1週間波浪予測モデルGWM to ANNの適用性
25. Clinical Features of Sjögrenʼs Syndrome Complicated with Anti-Aminoacyl-Trna Antibodies Syndrome: PS412
26. Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report
27. Field Observations on Water Temperature and Salinity Fields in Tanabe Bay in 2016
28. 田辺中島高潮観測塔における2016年夏季観測結果
29. Water Temperature Measurements by Small-Sized Thermometers Installed on Riverbed in Neighboring Rivers of Tanabe Bay
30. Uncommon mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901).
31. 3D calculation of curved open channel flow using physical curvilinear coordinates
32. PP01.118 First-line Nivolumab (N) + Ipilimumab (I) + Chemotherapy (C) in Metastatic NSCLC (mNSCLC): CheckMate 9LA 4-Year Clinical Update
33. Field Measurements at Tanabe-Nakashima Observation Tower in the Summer of 2015
34. Numerical Simulation of Riverbed Variation in Tonda River Using Simplified Lagrangian Model of Bedload Transport
35. A multicenter, open label, randomized phase III study of atezolizumab with platinum-pemetrexed and with or without bevacizumab for patients with advanced nonsquamous non-small cell lung cancer (WJOG11218L APPLE Study).
36. A randomized, double-blind, placebo-controlled phase III trial evaluating olanzapine 5 mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: J-FORCE Study.
37. REVISING WAVE INDUCED TURBULENT MIXING AND ITS IMPACT ON TROPICAL CYCLONE
38. ULTRASONIC BACKSCATTER MODEL ESTIMATING HEAT TRANSFER BY BUBBLE CLOUD IN THE OCEAN
39. ANALYSIS OF BERM DISSIPATION EFFECTS ON WAVE RUN-UP AND ITS INPLEMENTATION IN INTEGRATED FORMULA OF OVERTOPPING AND RUNUP MODELING
40. ONE WEEK WAVE PREDICTION METHOD APPLYING GMDH’S PARTIAL EXPRESSION TO GLOBAL WAVE FORECAST AND VALIDATING ACCURACY
41. RAINFALL OBSERVATION IN THE COASTAL AREA WITH OPTICAL DISDROMETERS IN THE SUMMER OF 2013
42. Olanzapine 5mg in Combination with Standard Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Cisplatin-Based Chemotherapy (J-FORCE): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
43. Measurements of Morphological Changes in Tonda River Estuary
44. Field Measurements at Tanabe-Nakashima Observation Tower in the Summer of 2014
45. Observed Features of Langmuir Turbulence Forced by Misaligned Wind and Waves Under Destabilizing Buoyancy Flux
46. Field Measurements at Tanabe-Nakashima Observation Tower in the Summer of 2013
47. Study on Bed-load Sorting around Series of Spur-dikes
48. REVISING WAVE INDUCED TURBULENT MIXING AND ITS IMPACT ON TROPICAL CYCLONE
49. Observed Features of Langmuir Turbulence Forced by Misaligned Wind and Waves under Destabilizing Buoyancy Flux
50. Clinical courses of peritoneal and pleural malignant mesothelioma, a single-center experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.